OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 562 full-time employees. The company went IPO on 2017-10-12. The firm is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The firm sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. The company markets 53 surgical and specialized bracing systems.
Mr. David Bailey is the President of OrthoPediatrics Corp, joining the firm since 2009.
What is the price performance of KIDS stock?
The current price of KIDS is $25.01, it has decreased 0% in the last trading day.
What are the primary business themes or industries for OrthoPediatrics Corp?
OrthoPediatrics Corp belongs to Health Care industry and the sector is Health Care
What is OrthoPediatrics Corp market cap?
OrthoPediatrics Corp's current market cap is $642.2M
Is OrthoPediatrics Corp a buy, sell, or hold?
According to wall street analysts, 11 analysts have made analyst ratings for OrthoPediatrics Corp, including 4 strong buy, 7 buy, 2 hold, 0 sell, and 4 strong sell